Prior to any cosmetic surgery procedure using a product intended to remain in the human body for more than thirty days, the practitioner responsible informs the person concerned, and, if applicable, their legal representative, of the risks and possible consequences and complications, in particular the limited lifespan of the product and any consequent need for re-intervention, as well as the expected undesirable effects.
A document containing the information given in application of the first paragraph is given to the person concerned and, if applicable, to their legal representative, at the same time as the estimate mentioned in article D. 6322-30.
A copy of this document, signed by the person concerned or their legal representative, is kept in the patient’s medical file referred to in article R. 1112-2. If the planned intervention is to take place outside a health establishment, the copy of the document is kept in the medical file kept by the practitioner who is going to perform the intervention using a product intended to remain in the human body for more than thirty days.